News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Obecure Signs Strategic Agreement with Farmaceutici-Formenti of the Grunenthal Group for Manufacturing and Supply of Betahistine in Europe



4/9/2008 8:23:26 AM

RAMAT GAN, Israel--(BUSINESS WIRE)--Obecure Ltd., a clinical stage company focused on development of novel therapeutics for weight management, announced today the execution of a strategic manufacturing and supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group (Grunenthal).

Read at BioSpace.com


comments powered by Disqus
Obecure
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES